Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vsee Health (VSEE) Shares Outstanding (Weighted Average) (2023 - 2025)

Vsee Health (VSEE) has disclosed Shares Outstanding (Weighted Average) for 3 consecutive years, with $16.5 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Outstanding (Weighted Average) rose 9.76% year-over-year to $16.5 million, compared with a TTM value of $16.5 million through Sep 2025, up 9.76%, and an annual FY2024 reading of $10.2 million, up 2.15% over the prior year.
  • Shares Outstanding (Weighted Average) was $16.5 million for Q3 2025 at Vsee Health, up from $16.4 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $16.5 million in Q3 2025 and bottomed at $4.2 million in Q1 2023.
  • Average Shares Outstanding (Weighted Average) over 3 years is $10.3 million, with a median of $10.0 million recorded in 2023.
  • The sharpest move saw Shares Outstanding (Weighted Average) grew 2.15% in 2024, then soared 251.59% in 2025.
  • Year by year, Shares Outstanding (Weighted Average) stood at $10.0 million in 2023, then increased by 2.15% to $10.2 million in 2024, then soared by 62.04% to $16.5 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for VSEE at $16.5 million in Q3 2025, $16.4 million in Q2 2025, and $16.3 million in Q1 2025.